Coronavirus Resource Hub

COVID-19 and Personalized Medicine: Current Status and Lessons Learned
By Personalized Medicine Coalition 14 September 2020
personalized medicines covid

Watch the recorded virtual discussion about COVID-19 and Personalized Medicine organized by the Personalized Medicine Coalition.


Scott Gottlieb, M.D., Resident Fellow, American Enterprise Institute

Antonio L. Andreu, M.D., Ph.D., Scientific Director, European Infrastructure for Translational Research

Michael Pellini, M.D., Managing Partner, Section 32

Michael Sherman, M.D., Senior Vice President, Chief Medical Officer, Harvard Pilgrim Health Care

Werner Verbiest, Strategic Partnerships and Alliances Leader, Janssen Pharmaceutical Companies of Johnson and Johnson

Jay G. Wohlgemuth, M.D., Senior Vice President, Chief Medical Officer, Quest Diagnostics

Go to the article